Is Azelaic Acid Safe in Pregnancy?

Azelaic acid is widely considered safe for use during pregnancy. It carries a former FDA pregnancy category B rating, meaning animal studies have not shown fetal harm and there is no evidence of risk in humans, though large controlled trials in pregnant women have not been conducted. Dermatology reviews consistently list it among the preferred topical treatments for skin conditions during pregnancy, and the limited systemic absorption of the drug provides a pharmacological reason for that comfort level.

Why the Safety Profile Looks Reassuring

Azelaic acid is a naturally occurring nine-carbon dicarboxylic acid already present in the human body as a byproduct of normal metabolism. Your skin, your gut bacteria, and even certain grains like wheat and barley all produce or contain it. That biological familiarity is part of why researchers have been relatively relaxed about its use during pregnancy compared to synthetic compounds.

The more concrete reassurance comes from how little of the topical form actually reaches your bloodstream. A pharmacokinetic study in humans found that only about 3.6% of the dose applied to the skin was absorbed systemically, based on urinary excretion data comparing topical and oral administration routes.¹ That is a small fraction. Whatever does enter circulation is quickly metabolized through beta-oxidation, the same energy pathway your body already uses to break down fatty acids, and excreted in urine. The result is that topical application at standard concentrations (15% or 20%) produces negligible systemic levels, which is a key reason the ingredient is not expected to pose a meaningful risk to a developing fetus.

The former pregnancy category B classification reinforces this. Under the old FDA letter system, category B meant that animal reproductive studies had failed to demonstrate a risk to the fetus, and adequate well-controlled studies in pregnant women were lacking but no signal of harm had emerged.² The FDA retired letter categories in 2015 in favor of a more descriptive labeling system, but dermatologists still reference category B as shorthand when discussing azelaic acid with patients.

Evidence from Actual Pregnancies

There are no randomized controlled trials specifically designed to test azelaic acid safety in pregnant women, and for ethical reasons, there likely never will be. What we do have are observational data and cohort studies, and they paint a consistent picture.

A large Nordic cohort study published in the British Journal of Dermatology looked at congenital malformation rates in pregnancies exposed to various topical treatments during the first trimester. Clindamycin and azelaic acid were used together as an active comparator group. Among the more than 11,000 infants whose mothers had used clindamycin or azelaic acid in the first trimester, about 2.6% had a recorded major congenital malformation. That was actually slightly below the 3.0% background rate among unexposed infants.³ The study’s primary aim was to evaluate topical retinoids, not azelaic acid, but the comparator data still provide some of the largest pregnancy exposure numbers we have for this ingredient.

A retrospective study specifically comparing topical treatments for acne during pregnancy looked at 20% azelaic acid alongside 4% erythromycin and 1% clindamycin. No significant difference in side effects was found between the groups. The study concluded that azelaic acid was the most successful option in terms of both effectiveness and patient satisfaction for mild-to-moderate pregnancy acne.⁴ This is not a large trial, but it does add real-world pregnancy data to the picture.

Conditions It Can Treat During Pregnancy

Pregnancy narrows your skincare options substantially, which makes a versatile ingredient like azelaic acid especially useful. It is not a one-trick product. Its mechanisms include antimicrobial activity against the bacteria involved in acne, inhibition of tyrosinase (the enzyme responsible for melanin production), and anti-inflammatory and antioxidant effects.⁵ That range of actions means it can address several of the skin problems that pregnancy tends to trigger or worsen.

Acne

Hormonal shifts during pregnancy often provoke acne flares, sometimes in people who had clear skin before conceiving. Azelaic acid is one of the few topical treatments that dermatologists consistently recommend for pregnant patients with mild-to-moderate acne.⁶ It works by reducing the colonization of acne-causing bacteria in pores and by normalizing the keratinization process that leads to clogged follicles. A 2013 review in Drugs specifically listed azelaic acid among the recommended first-line topical treatments for acne during pregnancy and lactation, alongside benzoyl peroxide and topical antibiotics like erythromycin and clindamycin.⁷

Melasma

Melasma, the patchy brown discoloration sometimes called “the mask of pregnancy,” is extremely common during pregnancy because rising estrogen and progesterone levels stimulate melanin production. Hydroquinone, the strongest over-the-counter depigmenting agent, is typically avoided during pregnancy because of its relatively high systemic absorption. Azelaic acid, with its tyrosinase-inhibiting ability, becomes one of the few credible options. A comparative study looking at topical therapy in pregnant women found that treatment led to a roughly 34% reduction in melasma severity scores over 16 weeks.⁸ That is a meaningful improvement, though it is not a complete resolution. Melasma during pregnancy often persists until hormone levels normalize postpartum, regardless of treatment.

Rosacea

Rosacea can also flare during pregnancy due to increased blood volume and hormonal changes. Azelaic acid in both 15% and 20% formulations is already an established rosacea treatment outside of pregnancy. A network meta-analysis comparing topical rosacea therapies found that 20% azelaic acid produced the highest effect size for improvement in clinical assessments, outperforming metronidazole and ivermectin.⁹ That study was not pregnancy-specific, but since azelaic acid is already considered pregnancy-compatible, the efficacy data translate to a practical advantage for pregnant patients who need rosacea management.

What the Side Effects Actually Feel Like

The side effects of azelaic acid are local, not systemic, and this holds true during pregnancy. The most common reactions are stinging, burning, or itching at the application site, usually in the first few weeks of use.² These sensations are typically mild and tend to fade as your skin adjusts. There are no reports of significant systemic adverse reactions or photosensitivity from topical azelaic acid use.

During pregnancy, your skin can be more sensitive than usual due to increased blood flow and hormonal changes, so the initial stinging may feel more pronounced than it would otherwise. A practical workaround is to start with every-other-day application for a week or two before moving to daily use, or to buffer the product by applying it over a thin layer of moisturizer. Neither approach has been studied in a formal trial, but dermatologists commonly suggest these strategies for sensitive skin.

If irritation persists beyond the first two to three weeks, it is worth mentioning to your provider, but switching to a lower concentration (15% instead of 20%) often resolves it. The 15% formulations, often gel-based, tend to be less irritating than the 20% cream formulations, though both are considered safe during pregnancy.

How It Compares to Other Pregnancy-Compatible Options

The short list of topical acne and pigmentation treatments considered acceptable during pregnancy includes benzoyl peroxide, certain topical antibiotics (erythromycin, clindamycin), and azelaic acid. Each has trade-offs that are worth understanding.

Benzoyl peroxide: Effective against acne bacteria and available over the counter, but it can bleach fabrics and cause significant dryness and peeling, which pregnant skin may tolerate poorly. It does nothing for pigmentation.
Topical erythromycin: Has a long track record in pregnancy but growing bacterial resistance has reduced its effectiveness over the years. It also has no benefit for melasma or rosacea.
Topical clindamycin: A solid acne option, often used in combination with benzoyl peroxide to limit resistance. Like erythromycin, it only addresses acne.
Azelaic acid: Uniquely versatile because it addresses acne, pigmentation, and rosacea in a single product. It can be used alone or alongside benzoyl peroxide or topical antibiotics. The retrospective pregnancy study mentioned earlier found it outperformed both erythromycin and clindamycin for acne effectiveness and patient satisfaction.⁴

The clear advantage of azelaic acid is that it handles multiple pregnancy skin concerns simultaneously. If you have acne and melasma, which is a common combination during pregnancy, azelaic acid is essentially the only single-ingredient topical that addresses both without posing safety concerns.

What You Should Definitely Avoid Instead

Understanding what is safe is easier when you also know what is clearly off the table. The skincare ingredients most firmly contraindicated during pregnancy are oral retinoids (isotretinoin), which are known teratogens that cause severe birth defects. Topical retinoids (tretinoin, adapalene, tazarotene) are also generally avoided during pregnancy as a precaution, even though the evidence of harm from topical use is not nearly as strong as for oral forms. The Nordic cohort study that used azelaic acid and clindamycin as comparators found that infants exposed to topical retinoids in the first trimester had a malformation rate of 3.3%, compared to 3.0% in unexposed infants and 2.6% in the azelaic acid and clindamycin group.³ The difference was not statistically significant, but dermatologists still advise avoiding topical retinoids during pregnancy given the known risks of the oral form and the availability of safer alternatives.

Other ingredients routinely avoided include oral tetracycline antibiotics (doxycycline, minocycline), which can affect fetal bone and tooth development, and high-dose salicylic acid, particularly in oral form. Hydroquinone, as noted earlier, is avoided due to its higher systemic absorption. Chemical sunscreens containing oxybenzone are also on many dermatologists’ caution lists, though the evidence there is more about precaution than demonstrated harm.

The practical takeaway is that pregnancy strips away most of the heavy hitters in a typical skincare routine. Retinoids, alpha-hydroxy acids at high concentrations, and strong depigmenting agents all come off the table. Azelaic acid fills a genuine gap in that landscape because it offers anti-acne, anti-pigmentation, and anti-inflammatory activity without the safety concerns attached to those other ingredients.

Prescription vs. Over-the-Counter Formulations

In the United States, azelaic acid at 15% (gel) and 20% (cream) concentrations is available by prescription under brand names like Finacea and Azelex. Over-the-counter products, typically marketed as cosmetic serums, usually contain 10% azelaic acid or less. In some other countries, 20% formulations are available without prescription.

The prescription-strength versions are the ones with the most clinical evidence behind them, including the pregnancy-related data discussed in this article. Over-the-counter 10% formulations can still be helpful for mild concerns, but if you are pregnant and dealing with moderate acne or noticeable melasma, the prescription concentration is likely to be more effective. The good news is that most dermatologists and obstetricians are familiar with azelaic acid’s pregnancy safety profile and are comfortable prescribing it. If your provider seems unfamiliar, the narrative reviews in dermatology journals consistently support its use during pregnancy and can serve as a reference point for the conversation.⁷

One formulation note worth knowing: some over-the-counter azelaic acid serums combine it with other active ingredients like niacinamide, salicylic acid, or various botanical extracts. During pregnancy, you want to check the full ingredient list rather than assuming the whole product is safe just because it contains azelaic acid. A serum that pairs azelaic acid with low-concentration salicylic acid (under 2%) is generally considered acceptable, but combinations with retinol or high-concentration chemical exfoliants should be avoided.

Timing and Realistic Expectations

Azelaic acid is not a fast-acting ingredient. Whether you are using it for acne or pigmentation, you should expect to wait four to eight weeks before seeing meaningful improvement. For melasma, the timeline is often longer, and complete clearance during pregnancy is unlikely because the hormonal driver is still active. The study looking at melasma in pregnant women showed a significant reduction in severity scores over 16 weeks, but that still left residual pigmentation in most patients.⁸

Managing expectations matters because the temptation during pregnancy is to escalate treatment when results are slow. Resist the urge to add stronger actives or layer multiple exfoliating products. Azelaic acid works best as a steady, consistent part of a simplified routine. Apply it once or twice daily to clean skin, follow with a moisturizer if needed, and use mineral sunscreen during the day, especially if melasma is the concern. Sun exposure is the single biggest aggravating factor for melasma, and no amount of azelaic acid will compensate for unprotected UV exposure.

For acne, continuing azelaic acid through the rest of pregnancy after you see initial improvement is reasonable, since stopping tends to invite flares. Many women find that their skin improves on its own in the second trimester as hormone levels stabilize, while others get worse in the third trimester. Having a safe, effective treatment already in your routine gives you flexibility regardless of how your skin behaves month to month.

After Delivery and During Breastfeeding

Azelaic acid’s safety profile extends into the postpartum and breastfeeding period. Given the very low systemic absorption from topical application, the amount that could theoretically reach breast milk is negligible. Dermatology reviews that address lactation list azelaic acid among the topical treatments considered compatible with breastfeeding, alongside benzoyl peroxide and topical antibiotics.⁷ This continuity is convenient: if you started azelaic acid during pregnancy, you do not need to stop and switch to something else after delivery.

Postpartum is also when many women notice their melasma beginning to fade as estrogen and progesterone drop. Continuing azelaic acid during this period can accelerate that fading. Once you are no longer pregnant or breastfeeding, the full range of skincare actives opens back up, and you can add retinoids or hydroquinone if residual pigmentation remains. But for the window when your options are limited, azelaic acid is one of the more effective tools available, and it carries essentially no additional risk to you or your baby.

1
PubMed. Percutaneous absorption of azelaic acid in humans
2
PubMed Central. Azelaic Acid: Mechanisms of Action and Clinical Applications
3
British Journal of Dermatology. Topical retinoid use in women of reproductive age and risk of major congenital malformations in exposed pregnancies: a Nordic cohort study
4
PubMed Central. Retrospective Analysis of Efficacy and Side Effects of Topical 4% Erythromycin Versus 1% Clindamycin Versus 20% Azelaic Acid During Pregnancy
5
Advances in Dermatology and Allergology. The multiple uses of azelaic acid in dermatology: mechanism of action, preparations, and potential therapeutic applications
6
PubMed Central. Treatment of Acne Vulgaris During Pregnancy and Lactation: A Narrative Review
7
PubMed. Treatment of acne vulgaris during pregnancy and lactation
8
Journal of Contemporary Clinical Practice. Efficacy of Topical and Systemic Therapies in Treating Melasma in Pregnant and Postpartum Women: A Comparative Study
9
PubMed Central. The efficacy and safety of minocycline, metronidazole, ivermectin, and azelaic acid in moderate-to-severe papulopustular rosacea: A systematic review and network meta-analysis